ChargePoint Adds US Office
ChargePoint Technology is expanding its US presence by opening a new office in San Francisco.
ChargePoint, a UK-headquartered company specializing in powder containment and aseptic transfer valves, will expand in North America by opening a new office in San Francisco, California. The new office will be the fourth globally, with other locations including Hong Kong and New Jersey.
“Growing our North American presence is a significant milestone for us and reflects our strategic vision to expand the company in key markets,” said Chris Eccles, CEO of ChargePoint, in a press release. “The use of split-valve technology is growing in popularity, and can offer an alternative to more cumbersome and costly containment techniques.”
Chris Rombach joins the team at the San Francisco office as president of ChargePoint Inc. He will be responsible for driving the growth of the entire ChargePoint offering across the United States, Canada, Mexico, and Puerto Rico, including the establishment of local sales operations and the creation of new roles in the US, as well as new reseller channels. The company plans to double its global workforce by 2020.
Source: ChargePoint
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
